The owners of US infant food firm Mead Johnson Nutrition Co. have announced plans to list part of the business on the stock market.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Pharmaceutical giant Bristol-Myers Squibb Co. said yesterday (15 September) that Mead Johnson had filed a registration statement with the US Securities and Exchange Commission for an IPO of its Class A common stock.
Bristol-Myers Squibb said it intends to keep a stake of at least 80% in the business, which sells a range of food for infants and children to over 50 countries worldwide.
In 2007, Mead Johnson generated annual sales of almost US$2.6bn.
Bristol-Myers Squibb said it expects the IPO to be finalised by the end of the first half of 2009.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData